1/15
07:46 am
indv
Indivior (NASDAQ:INDV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Indivior (NASDAQ:INDV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
1/12
07:17 am
indv
Indivior (NASDAQ:INDV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Indivior (NASDAQ:INDV) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/10
03:22 pm
indv
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance [Yahoo! Finance]
Low
Report
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance [Yahoo! Finance]
1/10
12:41 am
indv
Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation [Yahoo! Finance]
Low
Report
Indivior (NasdaqGS:INDV) Valuation Check After Strong Long Term Returns And Recent Price Consolidation [Yahoo! Finance]
1/8
07:00 am
indv
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
Low
Report
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
1/7
05:38 pm
indv
Is Indivior (NasdaqGS:INDV) Still Attractive After A 192% One Year Share Price Jump [Yahoo! Finance]
Low
Report
Is Indivior (NasdaqGS:INDV) Still Attractive After A 192% One Year Share Price Jump [Yahoo! Finance]
12/30
01:34 pm
indv
Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher [Yahoo! Finance]
Low
Report
Why This Top 100 Stock to Buy Is Getting Cheaper Even as It Soars Higher [Yahoo! Finance]
12/28
01:22 pm
indv
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table [Yahoo! Finance]
Low
Report
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table [Yahoo! Finance]
12/23
08:23 pm
indv
Indivior (NasdaqGS:INDV): Revisiting Valuation After S&P SmallCap 600 Inclusion and Strong Recent Share Price Gains [Yahoo! Finance]
Low
Report
Indivior (NasdaqGS:INDV): Revisiting Valuation After S&P SmallCap 600 Inclusion and Strong Recent Share Price Gains [Yahoo! Finance]
12/22
08:23 am
indv
Indivior PLC added to S&P SmallCap 600 Index [Seeking Alpha]
Low
Report
Indivior PLC added to S&P SmallCap 600 Index [Seeking Alpha]
12/22
07:18 am
indv
Indivior Announces Inclusion in the S&P SmallCap 600® Index [Yahoo! Finance]
Low
Report
Indivior Announces Inclusion in the S&P SmallCap 600® Index [Yahoo! Finance]
12/22
07:00 am
indv
Indivior Announces Inclusion in the S&P SmallCap 600® Index
Low
Report
Indivior Announces Inclusion in the S&P SmallCap 600® Index
12/17
12:06 pm
indv
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations [Yahoo! Finance]
Low
Report
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations [Yahoo! Finance]
12/17
11:30 am
indv
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
Low
Report
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
12/4
01:40 pm
indv
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
12/3
07:02 am
indv
Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
11/21
12:41 am
indv
A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge [Yahoo! Finance]
Medium
Report
A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge [Yahoo! Finance]
11/20
04:37 pm
indv
Indivior Concludes Legacy U.S. Department of Justice Matter [Yahoo! Finance]
Medium
Report
Indivior Concludes Legacy U.S. Department of Justice Matter [Yahoo! Finance]
11/20
04:01 pm
indv
Indivior Concludes Legacy U.S. Department of Justice Matter
Medium
Report
Indivior Concludes Legacy U.S. Department of Justice Matter
11/19
09:21 am
indv
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/5
07:31 am
indv
Indivior (NASDAQ:INDV) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Indivior (NASDAQ:INDV) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
11/3
08:00 am
indv
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
Medium
Report
Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine
10/31
12:25 pm
indv
Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $41.00 price target on the stock, up previously from $27.00.
Low
Report
Indivior (NASDAQ:INDV) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $41.00 price target on the stock, up previously from $27.00.
10/31
12:08 pm
indv
Indivior (NASDAQ:INDV) was given a new $40.00 price target on by analysts at Northland Securities.
Low
Report
Indivior (NASDAQ:INDV) was given a new $40.00 price target on by analysts at Northland Securities.
10/31
11:03 am
indv
Indivior (NASDAQ:INDV) had its "buy" rating reaffirmed by analysts at Craig Hallum.
Low
Report
Indivior (NASDAQ:INDV) had its "buy" rating reaffirmed by analysts at Craig Hallum.